BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//American Academy of Sleep Medicine – Association for Sleep Clinicians and Researchers - ECPv6.8.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:American Academy of Sleep Medicine – Association for Sleep Clinicians and Researchers
X-ORIGINAL-URL:https://aasm.org
X-WR-CALDESC:Events for American Academy of Sleep Medicine – Association for Sleep Clinicians and Researchers
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210525T100000
DTEND;TZID=America/New_York:20210525T110000
DTSTAMP:20260513T174501
CREATED:20210427T172632Z
LAST-MODIFIED:20210503T173224Z
UID:25953-1621936800-1621940400@aasm.org
SUMMARY:RBD – Past\, Present\, Future Part 2 Webcast 2021
DESCRIPTION:RBD – Past\, Present\, Future Part 2 Webcast 2021\nThe American Academy of Sleep Medicine presents a webcast on REM Sleep Behavior Disorder (RBD). RBD is parasomnia characterized by dream enactment in the context of loss of physiological atonia during REM sleep. RBD is of particular importance to sleep medicine\, neurology\, and neurosciences as it is one of the earliest manifestations of α-synuclein related neurodegeneration. The majority of patients with isolated RBD eventually develop Parkinson’s disease\, dementia with Lewy bodies\, or multiple system atrophy. Part 2 will focus on the associations between RBD and neurodegeneration and the significance of the RBD population for upcoming clinical trials to slow the progression of neurodegenerative disorders associated with RBD. \nRegister NowSpeakers\n\nRBD and Synuclein-specific Neurodegenerative Disorders\n\nRon Postuma\, MD – McGill University\, Canada\n\n\nBiomarkers of Neurodegeneration in RBD\n\nAmbra Stefani\, MD – University of Innsbruck\, Austria\n\n\nClinical Trials in RBD – Challenges and Opportunities \n\nAleksandar Videnovic\, MD – Harvard University\, USA
URL:https://aasm.org/event/rbd-past-present-future-part-2-webinar-2021/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://aasm.org/wp-content/uploads/2021/04/RBD_WebAds_aasm_event_790x480-e1619544075331.jpg
ORGANIZER;CN="AASM":MAILTO:courses@aasm.org
END:VEVENT
END:VCALENDAR